Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does KETOCONAZOLE Cause Intentional product use issue? 45 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Intentional product use issue have been filed in association with KETOCONAZOLE (Ketoconazole). This represents 0.8% of all adverse event reports for KETOCONAZOLE.

45
Reports of Intentional product use issue with KETOCONAZOLE
0.8%
of all KETOCONAZOLE reports
0
Deaths
1
Hospitalizations

How Dangerous Is Intentional product use issue From KETOCONAZOLE?

Of the 45 reports, 1 (2.2%) required hospitalization, and 1 (2.2%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for KETOCONAZOLE. However, 45 reports have been filed with the FAERS database.

What Other Side Effects Does KETOCONAZOLE Cause?

Drug ineffective (1,326) Off label use (657) Pruritus (559) Product use issue (428) Product use in unapproved indication (421) Alopecia (375) Therapeutic response unexpected (317) Psoriasis (312) Rash (267) Hair texture abnormal (255)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which KETOCONAZOLE Alternatives Have Lower Intentional product use issue Risk?

KETOCONAZOLE vs KETOPROFEN KETOCONAZOLE vs KETOPROFEN LYSINE KETOCONAZOLE vs KETOROLAC TROMETHAMINE KETOCONAZOLE vs KETOROLAC\KETOROLAC TROMETHAMINE KETOCONAZOLE vs KETOTIFEN

Related Pages

KETOCONAZOLE Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue KETOCONAZOLE Demographics